Tempest Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Tempest Therapeutics, Inc. (TPST) reported Increase (Decrease) in Other Operating Assets of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2021-05-13
- Tempest Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Tempest Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Tempest Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2020-09-30 was -$11.00K.
- Tempest Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2020-06-30 was -$11.00K.
- Tempest Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2020 was -$21.00K.
- Tempest Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2019 was -$66.00K.
- Tempest Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2021-05-13 | -$11.00K derived: sum of 3 quarters · filed 2021-05-13 | -$22.00K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$11.00K derived: sum of 2 quarters · filed 2021-03-29 | -$22.00K derived: sum of 3 quarters · filed 2021-03-29 | -$21.00K 10-K · filed 2021-03-29 | ||
| 2020-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$22.00K derived: sum of 2 quarters · filed 2020-11-09 | -$21.00K 10-Q · filed 2020-11-09 | $88.00K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2020-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$10.00K 10-Q · filed 2020-08-10 | $99.00K derived: sum of 3 quarters · filed 2021-05-13 | -$135.00K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-13 | $110.00K derived: sum of 2 quarters · filed 2021-05-13 | -$124.00K derived: sum of 3 quarters · filed 2021-05-13 | -$124.00K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$125.00K derived: sum of 2 quarters · filed 2021-03-29 | -$125.00K derived: sum of 3 quarters · filed 2021-03-29 | -$66.00K 10-K · filed 2021-03-29 | ||
| 2019-09-30 | -$234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$234.00K derived: sum of 2 quarters · filed 2020-11-09 | -$175.00K 10-Q · filed 2020-11-09 | -$297.00K 10-Q · filed 2019-11-13 | -$151.00K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $59.00K 10-Q · filed 2020-08-10 | -$62.00K 10-Q · filed 2019-08-12 | $83.00K derived: sum of 3 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $59.00K 10-Q · filed 2020-05-08 | $83.00K derived: sum of 2 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | -$24.00K 10-Q · filed 2018-11-09 | |||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |